Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Specify a stock or a cryptocurrency in the search bar to get a summary
Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Orexo AB
ORXCurrent price
10.4 SEK
-0.12 SEK (-1.14%)
Last closed
10.56 SEK
Company
www.orexo.com
ISIN
SE0000736415
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Exchange
Stockholm Exchange
Capitalization
364 635 446 SEK
Yield for 12 month
-32.73 %
1Y
3Y
5Y
10Y
15Y
ORX
Orexo AB (publ), a specialty pharmaceutical company, develops and commercializes pharmaceuticals and digital therapies in the United States, European Union, and internationally. Its products include Zubsolv tablets for the treatment of opioid use disorder; Abstral for the treatment of breakthrough pain in cancer patients; and Edluar for the treatment of insomnia. The company is developing OX124 for opioid overdose; OX125 for rescue medication and opioid overdose; OX640 for emergency treatment of allergic reactions; and OX-MPI for the treatment of endometriosis. In addition, its digital therapies include deprexis for the treatment of depression; vorvida for alcohol management; and modia for opioid use disorder. Orexo AB (publ) was founded in 1994 and is headquartered in Uppsala, Sweden. Address: Rapsgatan 7E, Uppsala, Sweden
Check your investment idea
Find the best to beat the market
TSLA
Tesla Motors
AAPL
Apple
MSFT
Microsoft
Analytics
WallStreet Target Price
543.34 SEKP/E ratio
–Dividend Yield
–Current Year
+640 288 476 SEK
Last Year
+625 754 687 SEK
Current Quarter
+136 818 056 SEK
Last Quarter
+154 358 835 SEK
Current Year
+473 901 678 SEK
Last Year
+522 915 624 SEK
Current Quarter
+116 671 227 SEK
Last Quarter
+117 172 392 SEK
Key Figures ORX
1 year
3 years
5 years
10 years
EBITDA
67 957 986 SEK
Operating Margin TTM
PE Ratio
–
Return On Assets TTM
1.12 %
PEG Ratio
–
Return On Equity TTM
-325 %
Wall Street Target Price
543.34 SEK
Revenue TTM
597 088 018 SEK
Book Value
-0.79 SEK
Revenue Per Share TTM
Dividend Share
–
Quarterly Revenue Growth YOY
-12.6 %
Dividend Yield
–
Gross Profit TTM
522 915 622 SEK
Earnings per share
-3.06 SEK
Diluted Eps TTM
-3.06 SEK
Most Recent Quarter
III 2024
Quarterly Earnings Growth YOY
485 %
Profit Margin
-17.68 %
Dividend Analytics ORX
Dividend growth over 5 years
–Continuous growth
–Payout Ratio 5 years average
–Dividend History ORX
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
–
Ex Dividend Date
–
Forward Annual Dividend Yield
–
Last Split Factor
1904:1903
Payout Ratio
–
Last Split Date
31.05.2011
Dividend Date
–
Stock Valuation ORX
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
–
Forward PE
9.1575
Enterprise Value Revenue
1.4148
Price Sales TTM
0.6107
Enterprise Value EBITDA
19.5542
Price Book MRQ
21.0683
Financials ORX
1 year
3 years
5 years
10 years
15 years
| Results | 2019 | Dynamics |
* The data for this period has not yet been published
Technical indicators ORX
For 52 weeks
10.32 SEK
23.35 SEK
50 Day MA
13.48 SEK
Shares Short Prior Month
–
200 Day MA
16.43 SEK
Short Ratio
–
Shares Short
–
Short Percent
–
BeatStart